Her primary areas of investigation include Epitope, Peptide sequence, Molecular biology, Biochemistry and Virology. Her research in Epitope intersects with topics in T cell, Ligand binding assay and Viral protein. Her study looks at the relationship between Peptide sequence and topics such as Major histocompatibility complex, which overlap with Cell.
Elisabetta Bianchi works in the field of Biochemistry, focusing on Peptide in particular. Her Virology research is multidisciplinary, relying on both Turn, Gp41, Antigen, Peptidomimetic and Binding site. In her study, which falls under the umbrella issue of Peptidomimetic, NS3, Protease and Stereochemistry is strongly linked to Product inhibition.
Elisabetta Bianchi spends much of her time researching Peptide, Biochemistry, Virology, NS3 and Stereochemistry. Her Peptide research incorporates themes from Amino acid, Peptide library, Cleavage and Receptor. Much of her study explores Biochemistry relationship to Molecular biology.
Her Virology study combines topics from a wide range of disciplines, such as Epitope, Antibody, Gp41, Antigen and Immune system. Her work focuses on many connections between NS3 and other disciplines, such as Serine protease, that overlap with her field of interest in Binding site. Her Stereochemistry research integrates issues from Solid-phase synthesis, Protein design, Sequence and Polyamide.
Her primary scientific interests are in Receptor, Internal medicine, Endocrinology, Glucagon and Peptide. Her Glucagon research is multidisciplinary, incorporating elements of Agonist and Dipeptidyl peptidase. Her research investigates the connection between Agonist and topics such as Oxyntomodulin that intersect with issues in Glucagon receptor.
Her Dipeptidyl peptidase study also includes fields such as
Elisabetta Bianchi mostly deals with Internal medicine, Receptor, Endocrinology, Glucagon and Oxyntomodulin. Her studies examine the connections between Internal medicine and genetics, as well as such issues in PEGylation, with regards to Glucagon-like peptide 1 receptor. Her Glucagon study integrates concerns from other disciplines, such as Agonist and Dipeptidyl peptidase.
Elisabetta Bianchi combines subjects such as Hormone and Peptide hormone with her study of Dipeptidyl peptidase. Her Endogeny research includes elements of Human serum albumin, Energy homeostasis, Anorectic and Peptide. Her Glucagon receptor study incorporates themes from Antagonist and Mechanism of action.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Alessandro Pocai;Paul E. Carrington;Jennifer R. Adams;Michael Wright.
Diabetes (2009)
Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments
Omar M.A El-Agnaf;Ross Jakes;Martin D Curran;Derek Middleton;Derek Middleton.
FEBS Letters (1998)
Solid Phase Synthesis of Peptide C-Terminal Thioesters by Fmoc/t-Bu Chemistry
Raffaele Ingenito;Elisabetta Bianchi;and Daniela Fattori;Antonello Pessi.
Journal of the American Chemical Society (1999)
Transcript imaging of the development of human T helper cells using oligonucleotide arrays
Lars Rogge;Elisabetta Bianchi;Mauro Biffi;Elisa Bono.
Nature Genetics (2000)
Identification of Amino Acid Residues in CD81 Critical for Interaction with Hepatitis C Virus Envelope Glycoprotein E2
Adrian Higginbottom;Elizabeth R. Quinn;Chiung-Chi Kuo;Mike Flint.
Journal of Virology (2000)
A designed metal-binding protein with a novel fold
Antonello Pessi;Elisabetta Bianchi;Andreas Crameri;Sara Venturini.
Nature (1993)
Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity.
Elisabetta Bianchi;Simona Denti;Alessandra Granata;Giovanna Bossi;Giovanna Bossi.
Nature (2000)
Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines
Bianchi Elisabetta;Pessi Antonello;Corradin Giampietro.
(1990)
Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products.
P Ingallinella;S Altamura;E Bianchi;M Taliani.
Biochemistry (1998)
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
Pessi Antonello;Bianchi Elisabetta;Verdini Antonio Silvio;Corradin Giampietro.
(1989)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Schering-Plough
University of Lausanne
Exiris
University of Milan
United States Military Academy
Sapienza University of Rome
Schering-Plough
University of Naples Federico II
United States Military Academy
Magna Graecia University
University of Southern California
Columbia University
Georgia Institute of Technology
Texas Christian University
Lund University
Jeonbuk National University
Polytechnic University of Milan
Austrian Academy of Sciences
Missouri Botanical Garden
Universidade de São Paulo
University of Glasgow
KTH Royal Institute of Technology
University of Oregon
University of Utah
University of Zurich